Associate Director – Quality, Mark King presents at Making Pharmaceuticals 2023
JensonR+ Associate Director – Quality, Mark King attended and presented at Making Pharmaceuticals 2023 – the leading UK Pharmaceutical conference and exhibition which featured over 200 companies exhibiting their latest products and services.
JensonR+ Associate Director, Quality Mark King presented as part of the Making Pharmaceuticals conference programme.
Mark is a Qualified Person, Responsible Person, and Responsible Person (import) with 30 years of experience working in the Pharmaceutical Industry in senior Quality Roles, covering GMP and GDP. He has extensive experience of leading successful MHRA GMDP Inspections and working closely with the MHRA Inspectorate teams.
Mark is the former Chair of the BGMA/MHRA Quality forum and the Current Chair of the QP Assessment panel for the Royal Society of Biology.
Mark’s presentation – Three “simple” steps to Achieving Sustainable Good Distribution Practice (GDP) Compliance – covered these areas:
1. The Why
- Legal requirement
- Business requirement
- THINK PATIENTS
2. The What
- Understanding the business model
3. The How
- Culture, people and behaviours
- GDP compliance including emerging trends and top MHRA inspection deficiencies.
- Sustainable GDP compliance
If you missed Mark at Making Pharmaceuticals 2023 but would like to discuss how JensonR+ can provide support at all levels, from strategy through to administration, please get in touch at consultancy@jensongroup.com
We have experts that are experienced in quality assurance, regulatory affairs, product development, drug safety, medical information, copy approval, project management, training and market access and they will be happy to talk to you about how we can meet your specific needs as your company moves from innovation and development to the market place.